Partnering within the biopharmaceutical industry is a key component of RBT’s growth strategy and is focused onto pipeline opportunities and our TargoSphere^® platform.

We seek to create a strong medical, scientific and commercial as well as cultural fit with partners to drive outstanding value for all parties.

Specifically, RBT seeks to out-license applications for vaccinations and/or treatments in the following areas:

• Infectious Diseases
• Malignant Diseases
• Chronic Inflammatory Diseases
• Autoimmune Diseases
• Atopic Diseases

We are also ready to co-develop and/or out-license applications for diagnostics.

Contact: business-development@biotargeting.eu

Partnering